Establishment of a bacterial infection model using the European honeybee, Apis mellifera L

Kenichi Ishii1, Hiroshi Hamamoto1, Kazuhisa Sekimizu1

  • 1Laboratory of Microbiology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Bunkyo-ku, Tokyo, Japan.

Plos One
|March 4, 2014
PubMed

Insights

Honeybees are susceptible to human pathogenic bacteria, with temperature significantly impacting survival. This research suggests honeybees can serve as a valuable model for studying bacterial infections and antibiotic efficacy in humans.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Animal Models

Background:

  • Human pathogenic bacteria can infect and kill honeybees (Apis mellifera L.).
  • Bacterial virulence factors and host factors influence honeybee susceptibility.
  • Antibiotic efficacy in honeybees mirrors mammalian models.

Purpose of the Study:

  • To investigate the pathogenicity of human bacteria in honeybees.
  • To evaluate the honeybee as a model organism for infectious disease research.
  • To assess the therapeutic potential of antibiotics in honeybee infections.

Main Methods:

  • Injection of human pathogenic bacteria into honeybee hemocoel.
  • Determination of lethal dose 50% (LD₅₀) values at different temperatures.
  • Assessment of virulence gene mutants and antibiotic efficacy.

Main Results:

  • Human pathogens like Staphylococcus aureus killed honeybees, with temperature significantly affecting mortality (LD₅₀ at 37°C vs. 15°C).
  • Mutants lacking specific virulence genes showed reduced bee-killing ability.
  • Antibiotics effective in humans also showed therapeutic effects in infected bees, with similar ED₅₀ values.

Conclusions:

  • Honeybees are a viable model for studying the pathogenesis of human-infecting bacteria.
  • The honeybee model can be used to evaluate the effectiveness of antibiotics.
  • Findings support the use of honeybees for preclinical assessment of antimicrobial therapies.

Related Concept Videos